Collectively, data recapitulated here suggest that miR-27a can be postulated as an oncomiRNA in colorectal cancer, where its expression was shown to be upregulated, and that it may support tumor progression through downregulation of CRT-dependent immunostimulation. The gene discussed is CALR; the disease is neoplasm.